title: Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care.
authors.affiliation: Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: vbarriosa@meditex.es.
authors.forename: Vivencio
authors.initials: V
authors.lastname: Barrios
authors.affiliation: Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain.
authors.forename: Carlos
authors.initials: C
authors.lastname: Escobar
authors.affiliation: Centro de Salud Rosa de Luxemburgo, San Sebastián de los Reyes, Madrid, Spain.
authors.forename: Alberto
authors.initials: A
authors.lastname: Calderón
authors.affiliation: Centro de Salud, La Puebla de Montalbán, Toledo, Spain.
authors.forename: Gustavo C
authors.initials: GC
authors.lastname: Rodríguez Roca
authors.affiliation: Centro de Salud Ingeniero Joaquín Benlloch, Valencia, Spain.
authors.forename: José Luis
authors.initials: JL
authors.lastname: Llisterri
authors.affiliation: Centro de Atención Primaria El Casar, Cáceres, Spain.
authors.forename: José
authors.initials: J
authors.lastname: Polo García
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011320:Primary Health Care; D018570:Risk Assessment; D020521:Stroke / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors